Mycosis fungoides plaque stage treated with topical nitrogen mustard with and without attempts at tolerance induction: report from the Scandinavian mycosis fungoides study group
- PMID: 84470
Mycosis fungoides plaque stage treated with topical nitrogen mustard with and without attempts at tolerance induction: report from the Scandinavian mycosis fungoides study group
Abstract
The Scandinavian Mycosis Fungoides Study Group has treated 21 patients with mycosis fungoides in plaque stages with topical, whole-body application of nitrogen mustard, 20 mg in 40 ml water per square metre. Ten patients were treated after previous attempts at intravenous tolerance induction ad modum van Scott & Kalmanson and eleven without. Complete remission was initially achieved in 10 patients and partial remission in 9 patients. Contact dermatitis to nitrogen mustard developed in 2/10 after tolerance induction and in 1/11 without tolerance induction. It is concluded that topical, whole-body application of nitrogen mustard gives high remission rates. In this series, however, many relapses occurred, due to inadequacy of the maintenance treatment. Tolerance induction has not been found of any value.
Similar articles
-
Topical nitrogen mustard in mycosis fungoides.Int J Clin Pharmacol Res. 1985;5(3):193-8. Int J Clin Pharmacol Res. 1985. PMID: 4018954
-
Topical nitrogen mustard in early mycosis fungoides. A 12-year experience.Acta Derm Venereol. 1985;65(1):53-8. Acta Derm Venereol. 1985. PMID: 2578706
-
Milia in regressing plaques of mycosis fungoides: provoked by topical nitrogen mustard or not?Int J Dermatol. 2004 Dec;43(12):953-6. doi: 10.1111/j.1365-4632.2004.01944.x. Int J Dermatol. 2004. PMID: 15569030
-
Topical mechlorethamine chemotherapy. Considerations on its use in mycosis fungoides.Int J Dermatol. 1984 Apr;23(3):180-6. doi: 10.1111/j.1365-4362.1984.tb04507.x. Int J Dermatol. 1984. PMID: 6373639 Review. No abstract available.
-
Clinical potential of mechlorethamine gel for the topical treatment of mycosis fungoides-type cutaneous T-cell lymphoma: a review on current efficacy and safety data.Drug Des Devel Ther. 2018 Jan 31;12:241-254. doi: 10.2147/DDDT.S137106. eCollection 2018. Drug Des Devel Ther. 2018. PMID: 29440874 Free PMC article. Review.
Cited by
-
Interventions for mycosis fungoides.Cochrane Database Syst Rev. 2020 Jul 7;7(7):CD008946. doi: 10.1002/14651858.CD008946.pub3. Cochrane Database Syst Rev. 2020. PMID: 32632956 Free PMC article.